Acquired cystic fibrosis transmembrane conductance regulator dysfunction

Area of Science:

• Respiratory physiology
• Epithelial biology
• Ion transport mechanisms

Background:

• The sinonasal respiratory epithelium uses mucociliary clearance (MCC) as a primary defense mechanism.
• Airway surface liquid (ASL) properties and ciliary function are vital for effective MCC.
• The cystic fibrosis transmembrane conductance regulator (CFTR) protein regulates ASL volume and viscosity.

Purpose of the Study:

• To review current understanding of acquired CFTR deficiency.
• To discuss CFTR-specific treatment strategies for chronic airway diseases.
• To highlight the role of CFTR in sinonasal and respiratory health.

Main Methods:

• Literature review of recent data on CFTR function and dysfunction.
• Analysis of therapeutic approaches targeting CFTR in chronic airway conditions.
• Synthesis of information on acquired CFTR deficiency.

Main Results:

• CFTR, an apical anion transporter, is crucial for maintaining ASL homeostasis.
• CFTR dysfunction affects both genetic cystic fibrosis and acquired conditions.
• Targeted CFTR treatments show promise for chronic rhinosinusitis (CRS).

Conclusions:

• Understanding acquired CFTR deficiency offers new therapeutic avenues.
• CFTR-modulating therapies are emerging as key treatments for CRS.
• Restoring CFTR function is critical for managing chronic airway diseases.